603676 卫信康
收盘竞价 08-04 14:56:54
资讯
新帖
简况
股市必读：卫信康新发布《西藏卫信康医药股份有限公司参与认购私募基金份额的公告》
证券之星 · 02:29
股市必读：卫信康新发布《西藏卫信康医药股份有限公司参与认购私募基金份额的公告》
每周股票复盘：卫信康（603676）独占许可协议终止不影响主业
证券之星 · 07-19
每周股票复盘：卫信康（603676）独占许可协议终止不影响主业
卫信康（603676）披露独占许可协议终止公告，7月17日股价下跌3.75%
证券之星 · 07-17
卫信康（603676）披露独占许可协议终止公告，7月17日股价下跌3.75%
卫信康最新公告：终止对乙酰氨基酚布洛芬注射液独占许可协议
证券之星 · 07-17
卫信康最新公告：终止对乙酰氨基酚布洛芬注射液独占许可协议
每周股票复盘：卫信康（603676）子公司获复合磷酸氢钾注射液注册证
证券之星 · 07-12
每周股票复盘：卫信康（603676）子公司获复合磷酸氢钾注射液注册证
卫信康最新公告：复合磷酸氢钾注射液获药品注册证书
证券之星 · 07-10
卫信康最新公告：复合磷酸氢钾注射液获药品注册证书
卫信康（603676）披露2025年年度权益分派实施公告，6月22日股价下跌0.69%
证券之星 · 06-22
卫信康（603676）披露2025年年度权益分派实施公告，6月22日股价下跌0.69%
每周股票复盘：卫信康（603676）拟出资1500万参投医疗健康基金
证券之星 · 05-31
每周股票复盘：卫信康（603676）拟出资1500万参投医疗健康基金
卫信康（603676）披露参与认购私募基金份额公告，5月27日股价下跌1.6%
证券之星 · 05-27
卫信康（603676）披露参与认购私募基金份额公告，5月27日股价下跌1.6%
每周股票复盘：卫信康（603676）2025年年度股东会审议通过利润分配等11项议案
证券之星 · 05-17
每周股票复盘：卫信康（603676）2025年年度股东会审议通过利润分配等11项议案
卫信康（603676）披露2025年年度股东会决议公告，5月14日股价下跌1.46%
证券之星 · 05-14
卫信康（603676）披露2025年年度股东会决议公告，5月14日股价下跌1.46%
股市必读：卫信康（603676）5月8日披露最新机构调研信息
证券之星 · 05-11
股市必读：卫信康（603676）5月8日披露最新机构调研信息
每周股票复盘：卫信康（603676）2025年现金分红总额141,373,479.60元
证券之星 · 05-10
每周股票复盘：卫信康（603676）2025年现金分红总额141,373,479.60元
股市必读：卫信康年报 - 第四季度单季净利润同比增长371.15%
证券之星 · 04-27
股市必读：卫信康年报 - 第四季度单季净利润同比增长371.15%
每周股票复盘：卫信康（603676）一季度净利降19.16%
证券之星 · 04-26
每周股票复盘：卫信康（603676）一季度净利降19.16%
卫信康(603676.SH)发布一季度业绩，归母净利润6834万元，同比下降19.16%
智通财经 · 04-23
卫信康(603676.SH)发布一季度业绩，归母净利润6834万元，同比下降19.16%
股市必读：卫信康（603676）3月23日收盘跌6.54%，主力净流出149.55万元
证券之星 · 03-24
股市必读：卫信康（603676）3月23日收盘跌6.54%，主力净流出149.55万元
突发涨价潮！维生素价格跳涨超35%，盈利拐点真的来了？
中金财经 · 03-19
突发涨价潮！维生素价格跳涨超35%，盈利拐点真的来了？
每周股票复盘：卫信康（603676）子公司获注射用硫酸艾沙康唑注册证
证券之星 · 03-08
每周股票复盘：卫信康（603676）子公司获注射用硫酸艾沙康唑注册证
卫信康(603676.SH)子公司获得注射用硫酸艾沙康唑药品注册证书
智通财经 · 03-06
卫信康(603676.SH)子公司获得注射用硫酸艾沙康唑药品注册证书
加载更多
公司概况
公司名称：
西藏卫信康医药股份有限公司
所属行业：
医药制造业
上市日期：
2017-07-21
主营业务：
西藏卫信康医药股份有限公司的主营业务是化学药品制剂及其原料药的研发、生产、销售。公司的主要产品是注射用多种维生素、多种微量元素注射液、小儿多种维生素注射液、复方氨基酸注射液、吸入用乙酰半胱氨酸溶液、复方电解质注射液、混合糖电解质注射液、门冬氨酸钾注射液、蔗糖铁注射液。
发行价格：
5.53
{"stockData":{"symbol":"603676","market":"SH","secType":"STK","nameCN":"卫信康","latestPrice":8.8,"timestamp":1785826614000,"preClose":8.86,"halted":0,"volume":2285700,"delay":0,"changeRate":-0.0068,"floatShares":434999999,"shares":434999999,"eps":0.4979,"marketStatus":"收盘竞价","change":-0.06,"latestTime":"08-04 14:56:54","open":8.88,"high":8.96,"low":8.79,"amount":20216800,"amplitude":0.0192,"askPrice":8.81,"askSize":64,"bidPrice":8.81,"bidSize":64,"shortable":0,"etf":0,"ttmEps":0.4979,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1785826800000},"marketStatusCode":4,"adr":0,"adjPreClose":8.86,"symbolType":"stock","openAndCloseTimeList":[[1785807000000,1785814200000],[1785819600000,1785826800000]],"highLimit":9.75,"lowLimit":7.97,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":435161500,"isCdr":false,"pbRate":2.5,"roa":"--","peRate":17.674232,"roe":"4.52%","epsLYR":0.54,"committee":0.117241,"marketValue":3829000000,"turnoverRate":0.0053,"status":1,"floatMarketCap":3829000000},"requestUrl":"/m/hq/s/603676","defaultTab":"news","newsList":[{"id":"2656830696","title":"股市必读：卫信康新发布《西藏卫信康医药股份有限公司参与认购私募基金份额的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656830696","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2656830696?lang=zh_cn&edition=full","pubTime":"2026-08-04 02:29","pubTimestamp":1785781752,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，卫信康报收于8.86元，上涨0.68%，换手率0.43%，成交量1.85万手，成交额1632.1万元。公司公告汇总：卫信康以自有资金2,000万元认缴上海齐济致胜创业投资基金份额，占比2.20%，投资方向为全球前沿医疗及生命科学技术领域。公司公告汇总西藏卫信康医药股份有限公司参与认购私募基金份额的公告西藏卫信康医药股份有限公司作为有限合伙人，以自有资金出资2,000万元认缴上海齐济致胜创业投资合伙企业份额，占基金已募集总额的2.20%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0191","09939","BK1515","BK1161","BK0239","BK1574","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652525837","title":"每周股票复盘：卫信康（603676）独占许可协议终止不影响主业","url":"https://stock-news.laohu8.com/highlight/detail?id=2652525837","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652525837?lang=zh_cn&edition=full","pubTime":"2026-07-19 03:33","pubTimestamp":1784403189,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，卫信康报收于8.99元，较上周的8.76元上涨2.63%。本周，卫信康7月16日盘中最高价报9.46元。本周关注点公司公告汇总：独占许可协议终止，合作产品处前期阶段 公司公告汇总西藏卫信康医药股份有限公司全资子公司中卫诚康与AFT公司签署《独占许可协议》，获对乙酰氨基酚布洛芬注射液中国大陆地区独占许可。本次终止不会对公司生产经营、核心业务及财务状况产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900001289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652029289","title":"卫信康（603676）披露独占许可协议终止公告，7月17日股价下跌3.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652029289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652029289?lang=zh_cn&edition=full","pubTime":"2026-07-17 22:45","pubTimestamp":1784299515,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，卫信康报收于8.99元，较前一交易日下跌3.75%，最新总市值为39.12亿元。近日，西藏卫信康医药股份有限公司发布《关于独占许可协议终止的公告》。公告显示，2024年9月27日，公司全资子公司中卫诚康与AFT公司签署《独占许可协议》，获得对乙酰氨基酚布洛芬注射液在中国大陆地区的独占许可。合作产品处于前期开发阶段，中卫诚康将在3个工作日内销毁AFT公司提供的全部资料并出具证明，AFT公司退还已支付的30万美元首付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700045209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652940925","title":"卫信康最新公告：终止对乙酰氨基酚布洛芬注射液独占许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2652940925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652940925?lang=zh_cn&edition=full","pubTime":"2026-07-17 17:18","pubTimestamp":1784279907,"startTime":"0","endTime":"0","summary":"卫信康(603676.SH)公告称，公司全资子公司中卫诚康与AFT公司签署的《独占许可协议》终止。因相关行业政策及市场环境变化，为合理配置资源，双方协商一致终止协议。AFT公司将退还已支付的首付款30万美元。本次终止不会对公司生产经营及财务状况产生重大影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700031621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650152843","title":"每周股票复盘：卫信康（603676）子公司获复合磷酸氢钾注射液注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2650152843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650152843?lang=zh_cn&edition=full","pubTime":"2026-07-12 03:19","pubTimestamp":1783797548,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，卫信康报收于8.76元，较上周的8.81元下跌0.57%。本周，卫信康7月6日盘中最高价报9.12元。本周关注点公司公告汇总：全资子公司获复合磷酸氢钾注射液药品注册证书，视同通过一致性评价。公司公告汇总西藏卫信康医药股份有限公司全资子公司内蒙古白医制药股份有限公司近日收到国家药品监督管理局核准签发的复合磷酸氢钾注射液《药品注册证书》，批准注册并视同通过一致性评价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200001258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650186561","title":"卫信康最新公告：复合磷酸氢钾注射液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2650186561","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650186561?lang=zh_cn&edition=full","pubTime":"2026-07-10 17:15","pubTimestamp":1783674912,"startTime":"0","endTime":"0","summary":"卫信康(603676.SH)公告称，全资子公司白医制药收到国家药监局核准签发的复合磷酸氢钾注射液药品注册证书。复合磷酸氢钾注射液在美国最早于1983年获批，用于纠正低磷血症和肠外营养支持，目前已在加拿大等国上市。原研参比制剂未在中国上市。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000030713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676","BK0239","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645075354","title":"卫信康（603676）披露2025年年度权益分派实施公告，6月22日股价下跌0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645075354","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645075354?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:58","pubTimestamp":1782140296,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，卫信康报收于8.58元，较前一交易日下跌0.69%，最新总市值为37.34亿元。该股当日开盘8.64元，最高8.71元，最低8.27元，成交额达2015.43万元，换手率为0.55%。近日，西藏卫信康医药股份有限公司发布《2025年年度权益分派实施公告》：每股现金红利0.18元（含税），股权登记日为2026年6月26日，除权（息）日和现金红利发放日均为2026年6月29日。根据持股期限不同，自然人股东股息红利所得税实行差别化税率。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603676","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639602876","title":"每周股票复盘：卫信康（603676）拟出资1500万参投医疗健康基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2639602876","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639602876?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:41","pubTimestamp":1780173669,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，卫信康报收于9.23元，较上周的9.66元下跌4.45%。本周，卫信康5月25日盘中最高价报9.73元。卫信康当前最新总市值40.17亿元，在化学制药板块市值排名107/150，在两市A股市值排名3845/5207。本周关注点公司公告汇总：卫信康拟出资1,500万元认购安徽华盖尔臻股权投资基金份额，占比5.29%。基金管理人为华盖资本有限责任公司，公司作为有限合伙人以出资额为限承担责任，无保本及最低收益承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","159760","603676","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638689010","title":"卫信康（603676）披露参与认购私募基金份额公告，5月27日股价下跌1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638689010","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638689010?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:44","pubTimestamp":1779893058,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘，卫信康报收于9.2元，较前一交易日下跌1.6%，最新总市值为40.03亿元。近日，西藏卫信康医药股份有限公司发布《参与认购私募基金份额的公告》。公告显示，公司拟作为有限合伙人出资1,500万元认购安徽华盖尔臻股权投资基金合伙企业份额，占基金已募集总额的5.29%。基金管理人为华盖资本有限责任公司，公司作为有限合伙人以出资额为限承担责任，无保本及最低收益承诺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700046402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636306266","title":"每周股票复盘：卫信康（603676）2025年年度股东会审议通过利润分配等11项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2636306266","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636306266?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:17","pubTimestamp":1778962630,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，卫信康报收于10.06元，较上周的10.51元下跌4.28%。本周，卫信康5月11日盘中最高价报10.7元。本周关注点公司公告汇总：卫信康2025年年度股东会审议通过2025年度利润分配方案等11项议案。公司公告汇总西藏卫信康医药股份有限公司于2026年5月14日召开2025年年度股东会，会议由董事会召集，董事长张勇主持，采用现场与网络投票结合方式召开。出席会议股东共207人，代表有表决权股份276,474,955股，占公司总股本的63.9493%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635465897","title":"卫信康（603676）披露2025年年度股东会决议公告，5月14日股价下跌1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635465897","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635465897?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:42","pubTimestamp":1778769737,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，卫信康报收于10.15元，较前一交易日下跌1.46%，最新总市值为44.17亿元。该股当日开盘10.27元，最高10.29元，最低10.15元，成交额达1608.93万元，换手率为0.36%。近日，西藏卫信康医药股份有限公司发布《2025年年度股东会决议公告》。公告显示，公司于2026年5月14日召开2025年年度股东会，出席会议股东共207人，代表有表决权股份276,474,955股，占公司总股本的63.9493%。其中议案6和议案10为特别决议议案，获出席股东所持表决权三分之二以上通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400043260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634742996","title":"股市必读：卫信康（603676）5月8日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2634742996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634742996?lang=zh_cn&edition=full","pubTime":"2026-05-11 04:04","pubTimestamp":1778443456,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，卫信康报收于10.51元，上涨0.48%，换手率0.34%，成交量1.48万手，成交额1551.43万元。交易信息汇总资金流向5月8日主力资金净流出97.8万元，占总成交额6.3%；游资资金净流出47.61万元，占总成交额3.07%；散户资金净流入145.41万元，占总成交额9.37%。2025年度现金分红总额为141,373,479.60元，占归母净利润的60.71%。董事会提请股东大会授权其在符合条件时制定2026年中期利润分配方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","603676","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634441216","title":"每周股票复盘：卫信康（603676）2025年现金分红总额141,373,479.60元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634441216","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634441216?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:38","pubTimestamp":1778355491,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，卫信康报收于10.51元，较上周的10.6元下跌0.85%。本周，卫信康5月6日盘中最高价报10.74元。卫信康当前最新总市值45.74亿元，在化学制药板块市值排名106/150，在两市A股市值排名3764/5200。来自机构调研要点：公司将以临床需求为导向，向围手术期及儿科用药方向发展。2025年度现金分红总额141,373,479.60元，占本年度归属于上市公司股东净利润的60.71%。董事会提请股东会授权董事会在满足条件的前提下制定2026年中期利润分配方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603676","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630358589","title":"股市必读：卫信康年报 - 第四季度单季净利润同比增长371.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630358589","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630358589?lang=zh_cn&edition=full","pubTime":"2026-04-27 09:29","pubTimestamp":1777253362,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，卫信康报收于10.38元，上涨1.76%，换手率0.71%，成交量3.09万手，成交额3194.51万元。来自：卫信康2025年归母净利润2.33亿元，同比下降5.41%；但第四季度归母净利润同比上升371.15%。股本股东变化股东户数变动近日卫信康披露，截至2026年3月31日公司股东户数为1.57万户，较12月31日增加100.0户，增幅为0.64%。分红金额上限为当期归属于上市公司股东净利润的100%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700009262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630807090","title":"每周股票复盘：卫信康（603676）一季度净利降19.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630807090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630807090?lang=zh_cn&edition=full","pubTime":"2026-04-26 06:31","pubTimestamp":1777156264,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，卫信康报收于10.38元，较上周的10.25元上涨1.27%。本周，卫信康4月20日盘中最高价报10.45元。业绩披露要点卫信康2026年一季报显示，公司主营收入3.22亿元，同比增长8.9%；归母净利润6833.93万元，同比下降19.16%；扣非净利润6794.85万元，同比下降8.61%；负债率20.83%，投资收益269.35万元，财务费用-15.23万元，毛利率60.19%。本年度现金分红总额141,373,479.60元，现金分红和股份回购金额合计占归属于上市公司股东净利润的60.71%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600003977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629883206","title":"卫信康(603676.SH)发布一季度业绩，归母净利润6834万元，同比下降19.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629883206","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629883206?lang=zh_cn&edition=full","pubTime":"2026-04-23 21:11","pubTimestamp":1776949862,"startTime":"0","endTime":"0","summary":"智通财经APP讯，卫信康(603676.SH)披露2026年第一季度报告，报告期公司实现营收3.22亿元，同比增长8.90%;归母净利润6834万元，同比下降19.16%;扣非净利润6795万元，同比下降8.61%。基本每股收益0.16元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621015084","title":"股市必读：卫信康（603676）3月23日收盘跌6.54%，主力净流出149.55万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621015084","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621015084?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:31","pubTimestamp":1774297870,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，卫信康报收于9.72元，下跌6.54%，换手率0.79%，成交量3.43万手，成交额3394.06万元。当日关注点来自交易信息汇总：卫信康股价3月23日收跌6.54%，报9.72元，已连续3日下跌。来自资金流向：主力资金3月23日净流出149.55万元，占总成交额4.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400005072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0191","BK0239","603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620246290","title":"突发涨价潮！维生素价格跳涨超35%，盈利拐点真的来了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2620246290","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620246290?lang=zh_cn&edition=full","pubTime":"2026-03-19 18:00","pubTimestamp":1773914401,"startTime":"0","endTime":"0","summary":"核心品种价格持续走高从具体品类来看，维生素A、维生素E成为本轮涨价的核心品种，涨幅明显且传导迅速。在成本端上游化工原料涨价，以及油运价格上涨等因素刺激下，业内控产涨价意愿强烈。机构扎堆调研维生素价格上涨快速传导至资本市场，产业链上市公司成为机构关注的重点标的，调研次数大幅增加。维生素品类价格自去年第四季度以来已实现企稳回升。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202603/19/20260319780631.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202603/19/20260319780631.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260319/32081868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0197","002001","LU0405327148.USD","BK0028","603079","BK0191","BK0077","BK0070","BK0187","LU0405327494.USD","002562","BK0186","BK0226","603676","BK0188","002626","BK0201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617636246","title":"每周股票复盘：卫信康（603676）子公司获注射用硫酸艾沙康唑注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2617636246","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617636246?lang=zh_cn&edition=full","pubTime":"2026-03-08 03:14","pubTimestamp":1772910853,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，卫信康报收于10.91元，较上周的11.23元下跌2.85%。本周，卫信康3月2日盘中最高价报11.22元。本周关注点来自公司公告汇总：子公司获注射用硫酸艾沙康唑药品注册证书，视同通过一致性评价。公司公告汇总西藏卫信康医药股份有限公司全资子公司内蒙古白医制药股份有限公司近日收到国家药品监督管理局核准签发的注射用硫酸艾沙康唑《药品注册证书》，批准注册并视同通过一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0191","603676"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617686498","title":"卫信康(603676.SH)子公司获得注射用硫酸艾沙康唑药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2617686498","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617686498?lang=zh_cn&edition=full","pubTime":"2026-03-06 17:37","pubTimestamp":1772789822,"startTime":"0","endTime":"0","summary":"智通财经APP讯，卫信康(603676.SH)发布公告，近日，公司全资子公司内蒙古白医制药股份有限公司(简称“白医制药”)收到国家药品监督管理局核准签发的注射用硫酸艾沙康唑《药品注册证书》。注射用硫酸艾沙康唑适用于治疗成人患者下列感染：侵袭性曲霉病，侵袭性毛霉病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"卫信康(603676.SH)子公司获得注射用硫酸艾沙康唑药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603676","BK0191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785826725590,"stockEarnings":[{"period":"1week","weight":0.035},{"period":"1month","weight":0.0057},{"period":"3month","weight":-0.1456},{"period":"6month","weight":-0.195},{"period":"1year","weight":-0.3007},{"period":"ytd","weight":-0.1391}],"compareEarnings":[{"period":"1week","weight":-0.0126},{"period":"1month","weight":-0.0579},{"period":"3month","weight":-0.0736},{"period":"6month","weight":-0.0713},{"period":"1year","weight":0.0701},{"period":"ytd","weight":-0.0401}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏卫信康医药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"15688人(较上一季度增加0.64%)","perCapita":"27738股","listingDate":"2017-07-21","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区B区园区南路5号工业中心4号楼3层","registeredCapital":"43516万元","survey":" 西藏卫信康医药股份有限公司的主营业务是化学药品制剂及其原料药的研发、生产、销售。公司的主要产品是注射用多种维生素、多种微量元素注射液、小儿多种维生素注射液、复方氨基酸注射液、吸入用乙酰半胱氨酸溶液、复方电解质注射液、混合糖电解质注射液、门冬氨酸钾注射液、蔗糖铁注射液。","listedPrice":5.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"卫信康(603676)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供卫信康(603676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"卫信康,603676,卫信康股票,卫信康股票老虎,卫信康股票老虎国际,卫信康行情,卫信康股票行情,卫信康股价,卫信康股市,卫信康股票价格,卫信康股票交易,卫信康股票购买,卫信康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"卫信康(603676)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供卫信康(603676)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}